Publications by authors named "J Burghofer"

Claim this Profile
N
NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data.
A Reichinger, A Friedrich, T Lentner, H Taghizadeh, P Reimann, J Burghofer

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.
Andreas Reichinger, Leo Essl, Paul Kerschner, Jonathan Burghofer, Gerald Webersinke

Oncologist· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment.
Stefan Tatalovic, Bernhard Doleschal, Alexander Kupferthaler, Stephan Grundner, Jonathan Burghofer

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.
Patrick Reimann, Ilektra-Antonia Mavroeidi, Jonathan Burghofer, Hossein Taghizadeh, Gerald Webersinke

Cancer Immunol Immunother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity.
I-A Mavroeidi, J Burghofer, S Kalbourtzis, H Taghizadeh, G Webersinke

ESMO Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis